The novel treatment of the medication represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and the GIP hormone – providing improved sugar management and anticipated weight reduction. Scientists are explorin